Clinical Trial Update: Effect of Tepotinib on the PK of the P-gp Substrate Dabigatran Etexilate [Phase 1]

View source ↗

Summary

Phase 1 trial updates the effect of tepotinib on the pharmacokinetics of the P-gp substrate dabigatran etexilate in healthy participants; results have been post…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Healthy Volunteers

Drugs mentioned

• Dabigatran etexilate (Dabigatran etexilate)
• Tepotinib (tepotinib)

Snippet

Sponsor: Merck KGaA, Darmstadt, Germany | Conditions: Healthy | Phase 1 | Status: COMPLETED | Results posted: 2023-08-07